JP2011188872A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011188872A5 JP2011188872A5 JP2011148711A JP2011148711A JP2011188872A5 JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5 JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011148711 A JP2011148711 A JP 2011148711A JP 2011188872 A5 JP2011188872 A5 JP 2011188872A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- cell
- interleukin
- dendritic cells
- immature dendritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31759201P | 2001-09-06 | 2001-09-06 | |
| US60/317,592 | 2001-09-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Division JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015040165A Division JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011188872A JP2011188872A (ja) | 2011-09-29 |
| JP2011188872A5 true JP2011188872A5 (enExample) | 2012-10-18 |
| JP5777956B2 JP5777956B2 (ja) | 2015-09-16 |
Family
ID=32654226
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Pending JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
| JP2011148711A Expired - Fee Related JP5777956B2 (ja) | 2001-09-06 | 2011-07-04 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
| JP2015040165A Expired - Fee Related JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003526345A Pending JP2005505270A (ja) | 2001-09-06 | 2002-09-06 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015040165A Expired - Fee Related JP6114768B2 (ja) | 2001-09-06 | 2015-03-02 | 単球性樹状細胞およびｔ細胞にｔｈ−１応答をプライミングするための組成物および方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050059151A1 (enExample) |
| EP (3) | EP2322603B1 (enExample) |
| JP (3) | JP2005505270A (enExample) |
| KR (3) | KR20050027163A (enExample) |
| CN (2) | CN1636229B (enExample) |
| AU (1) | AU2008221592B2 (enExample) |
| BR (1) | BRPI0212545B8 (enExample) |
| CA (1) | CA2459713C (enExample) |
| DK (2) | DK2322603T3 (enExample) |
| ES (2) | ES2598109T3 (enExample) |
| IL (3) | IL160720A0 (enExample) |
| MX (1) | MXPA04002147A (enExample) |
| NO (2) | NO338147B1 (enExample) |
| NZ (1) | NZ531530A (enExample) |
| PL (1) | PL372098A1 (enExample) |
| PT (2) | PT2322603T (enExample) |
| WO (1) | WO2003022215A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT412145B (de) * | 2002-09-13 | 2004-10-25 | Forsch Krebskranke Kinder | Verfahren zur herstellung eines zellulären immuntherapeutikums auf basis von il-12-freisetzenden dendritischen zellen |
| US20040057935A1 (en) * | 2002-09-20 | 2004-03-25 | Cedars-Sinai Medical Center | Intratumoral delivery of dendritic cells |
| EP2260861A1 (en) * | 2002-12-06 | 2010-12-15 | NorthWest Biotherapeutics, Inc. | Administration of dendritic cells partially matured in vitro for the treatment of tumors |
| ES2321939T3 (es) * | 2003-02-27 | 2009-06-15 | Northwest Biotherapeutics, Inc. | Generacion de celulas dendriticas a partir de celulas precursoras dendriticas monociticas con gm-csf en ausencia de citoquinas adicionales. |
| EP1484064A1 (en) | 2003-06-04 | 2004-12-08 | Gesellschaft für Biotechnologische Forschung | Therapeutical composition containing dentritic cells and use thereof |
| EP1670513B1 (en) * | 2003-10-06 | 2013-01-23 | Cedars-Sinai Medical Center | Cox-2 inhibitors and dendritic cells for use in the treatment of cancer. |
| US7939090B2 (en) * | 2003-10-21 | 2011-05-10 | Cedars-Sinai Medical Center | System and method for the treatment of cancer, including cancers of the central nervous system |
| CN1902312B (zh) * | 2003-11-04 | 2011-02-23 | 株式会社载体研究所 | 制备导入了基因的树突细胞的方法 |
| CA2571844A1 (en) | 2004-06-24 | 2006-01-05 | Dnavec Research Inc. | Anticancer agent containing minus-strand rna virus |
| CA2632263C (en) * | 2005-12-08 | 2022-01-11 | Northwest Biotherapeutics, Inc. | Compositions and methods for inducing the activation of immature monocytic dendritic cells |
| EP1840206A1 (en) * | 2006-03-28 | 2007-10-03 | Gsf-Forschungszentrum Für Umwelt Und Gesundheit, Gmbh | Compositions for the preparation of mature dendritic cells |
| US8129184B2 (en) * | 2006-09-26 | 2012-03-06 | Cedars-Sinai Medical Center | Cancer stem cell antigen vaccines and methods |
| US8871211B2 (en) | 2006-09-28 | 2014-10-28 | Cedars-Sinai Medical Center | Cancer vaccines and vaccination methods |
| PL2328923T3 (pl) * | 2008-09-02 | 2016-06-30 | Cedars Sinai Medical Center | Epitopy CD133 |
| ES2618573T3 (es) | 2009-05-07 | 2017-06-21 | ImmunoCellular Therapeutics,Ltd | Epítopos de CD133 |
| KR20140143361A (ko) * | 2012-02-02 | 2014-12-16 | 캘리포니아 스템 셀, 인코포레이티드 | 다능성 배엽층 기원 항원 제시 암 백신 |
| WO2013180481A1 (ko) * | 2012-05-31 | 2013-12-05 | 제이더블유크레아젠 주식회사 | 수지상세포 성숙화 조성물 및 이를 이용하여 항원 특이적 수지상세포를 제조하는 방법 |
| US20140065173A1 (en) | 2012-09-06 | 2014-03-06 | Orbis Health Solutions Llc | Tumor lysate loaded particles |
| AU2020203845C1 (en) * | 2012-09-06 | 2022-08-11 | Orbis Health Solutions, Llc | Tumor lysate loaded particles |
| WO2014093454A1 (en) | 2012-12-12 | 2014-06-19 | Orbis Health Solutions, Llc | Compositions and methods for tissue regeneration |
| US20140234351A1 (en) | 2013-02-14 | 2014-08-21 | Immunocellular Therapeutics, Ltd. | Cancer vaccines and vaccination methods |
| CN104936612B (zh) * | 2013-09-05 | 2021-01-01 | 奥比思健康解决方案有限责任公司 | 装载了肿瘤裂解物的微粒 |
| CN106456532B (zh) | 2014-03-05 | 2020-07-24 | 奥比思健康解决方案有限责任公司 | 使用酵母细胞壁颗粒的疫苗递送系统 |
| US10373259B1 (en) | 2014-05-20 | 2019-08-06 | State Farm Mutual Automobile Insurance Company | Fully autonomous vehicle insurance pricing |
| US9858621B1 (en) | 2014-05-20 | 2018-01-02 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle technology effectiveness determination for insurance pricing |
| US10599155B1 (en) | 2014-05-20 | 2020-03-24 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation feature monitoring and evaluation of effectiveness |
| US9972054B1 (en) | 2014-05-20 | 2018-05-15 | State Farm Mutual Automobile Insurance Company | Accident fault determination for autonomous vehicles |
| US11669090B2 (en) | 2014-05-20 | 2023-06-06 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation feature monitoring and evaluation of effectiveness |
| US9786154B1 (en) | 2014-07-21 | 2017-10-10 | State Farm Mutual Automobile Insurance Company | Methods of facilitating emergency assistance |
| US10336321B1 (en) | 2014-11-13 | 2019-07-02 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle control assessment and selection |
| JP6985939B2 (ja) * | 2015-06-30 | 2021-12-22 | ノースウエスト バイオセラピューティクス，インコーポレイティド | 改善または増大した抗腫瘍免疫応答を誘導する最適に活性化された樹状細胞 |
| WO2017002045A1 (en) | 2015-06-30 | 2017-01-05 | Stemlab, Sa | A viable cell population, method for production and uses thereof |
| US20210272207A1 (en) | 2015-08-28 | 2021-09-02 | State Farm Mutual Automobile Insurance Company | Vehicular driver profiles and discounts |
| US11441916B1 (en) | 2016-01-22 | 2022-09-13 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle trip routing |
| US10395332B1 (en) | 2016-01-22 | 2019-08-27 | State Farm Mutual Automobile Insurance Company | Coordinated autonomous vehicle automatic area scanning |
| US11719545B2 (en) | 2016-01-22 | 2023-08-08 | Hyundai Motor Company | Autonomous vehicle component damage and salvage assessment |
| US10134278B1 (en) | 2016-01-22 | 2018-11-20 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle application |
| US11242051B1 (en) | 2016-01-22 | 2022-02-08 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle action communications |
| US10324463B1 (en) | 2016-01-22 | 2019-06-18 | State Farm Mutual Automobile Insurance Company | Autonomous vehicle operation adjustment based upon route |
| US10482226B1 (en) | 2016-01-22 | 2019-11-19 | State Farm Mutual Automobile Insurance Company | System and method for autonomous vehicle sharing using facial recognition |
| KR102038114B1 (ko) * | 2016-02-26 | 2019-10-30 | 주식회사 엘지화학 | 광학 점착제용 (메타)아크릴레이트기 함유 벤조페논의 제조방법 및 광학 점착제 조성물 |
| WO2018160666A1 (en) * | 2017-02-28 | 2018-09-07 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Short-term activated dc1s and methods for their production and use |
| WO2019183924A1 (en) * | 2018-03-30 | 2019-10-03 | Syz Cell Therapy Co. | Improved multiple antigen specific cell therapy methods |
| CA3157004A1 (en) * | 2019-10-07 | 2021-04-15 | Northwest Biotherapeutics, Inc. | In vitro methods and compositions for enhancing the activation of dendritic cells and t cells, and for inducing a th-1 immune response |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5162504A (en) | 1988-06-03 | 1992-11-10 | Cytogen Corporation | Monoclonal antibodies to a new antigenic marker in epithelial prostatic cells and serum of prostatic cancer patients |
| US5366866A (en) * | 1991-07-25 | 1994-11-22 | Duke University | Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB |
| US5227471A (en) * | 1992-01-30 | 1993-07-13 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma |
| US5788963A (en) * | 1995-07-31 | 1998-08-04 | Pacific Northwest Cancer Foundation | Isolation and/or preservation of dendritic cells for prostate cancer immunotherapy |
| EA199800272A1 (ru) * | 1995-10-04 | 1998-10-29 | Иммунекс Корпорейшн | Фактор, стимулирующий дендритные клетки |
| US7659119B2 (en) * | 1996-02-12 | 2010-02-09 | Argos Therapeutics, Inc. | Method and compositions for obtaining mature dendritic cells |
| DE69840739D1 (de) * | 1997-10-27 | 2009-05-28 | Merix Bioscience Inc | Methode und Zusammensetzung zur Herstellung von reifen dendritischen Zellen |
| JP2000143534A (ja) * | 1998-11-13 | 2000-05-23 | Asahi Chem Ind Co Ltd | 樹状細胞ワクチン及びその製造方法 |
| JP2000279181A (ja) * | 1999-04-01 | 2000-10-10 | Japan Science & Technology Corp | ヒト樹状細胞の発現遺伝子群 |
| US20030108527A1 (en) * | 1999-12-28 | 2003-06-12 | Tsukasa Seya | Maturation-promoting agent for immature dendrtic cells |
| US6247378B1 (en) * | 2000-01-06 | 2001-06-19 | Deere & Company | Operator control device for an infinitely variable transmission |
| DK1292321T3 (da) * | 2000-05-12 | 2012-01-30 | Northwest Biotherapeutics Inc | Fremgangsmåde til at forøge klasse 1 præsentation af exogene antigener gennem humane dendritiske celler |
| AU2002240877B2 (en) * | 2001-01-15 | 2007-03-29 | I.D.M. Immuno-Designed Molecules | Ancillary composition for the preparation of committed mature dendritic cells |
| WO2003010292A2 (en) * | 2001-07-25 | 2003-02-06 | Northwest Biotherapeutics, Inc. | Methods and apparatus for enrichment and culture of monocytic dendritic cell precursors |
-
2002
- 2002-09-06 EP EP10181985.2A patent/EP2322603B1/en not_active Expired - Lifetime
- 2002-09-06 PL PL02372098A patent/PL372098A1/xx not_active Application Discontinuation
- 2002-09-06 CA CA2459713A patent/CA2459713C/en not_active Expired - Lifetime
- 2002-09-06 DK DK10181985.2T patent/DK2322603T3/da active
- 2002-09-06 ES ES02761594.7T patent/ES2598109T3/es not_active Expired - Lifetime
- 2002-09-06 DK DK02761594.7T patent/DK1441591T3/en active
- 2002-09-06 KR KR1020047003386A patent/KR20050027163A/ko not_active Ceased
- 2002-09-06 CN CN028198174A patent/CN1636229B/zh not_active Expired - Fee Related
- 2002-09-06 KR KR1020117012621A patent/KR20110081341A/ko not_active Ceased
- 2002-09-06 JP JP2003526345A patent/JP2005505270A/ja active Pending
- 2002-09-06 NZ NZ531530A patent/NZ531530A/en not_active IP Right Cessation
- 2002-09-06 KR KR1020147023675A patent/KR101803702B1/ko not_active Expired - Lifetime
- 2002-09-06 ES ES10181985T patent/ES2766299T3/es not_active Expired - Lifetime
- 2002-09-06 PT PT101819852T patent/PT2322603T/pt unknown
- 2002-09-06 WO PCT/US2002/028620 patent/WO2003022215A2/en not_active Ceased
- 2002-09-06 EP EP02761594.7A patent/EP1441591B1/en not_active Expired - Lifetime
- 2002-09-06 PT PT2761594T patent/PT1441591T/pt unknown
- 2002-09-06 IL IL16072002A patent/IL160720A0/xx unknown
- 2002-09-06 MX MXPA04002147A patent/MXPA04002147A/es active IP Right Grant
- 2002-09-06 CN CN201210470111.XA patent/CN102973928B/zh not_active Expired - Fee Related
- 2002-09-06 US US10/488,744 patent/US20050059151A1/en not_active Abandoned
- 2002-09-06 BR BRPI0212545A patent/BRPI0212545B8/pt not_active IP Right Cessation
- 2002-09-06 EP EP19202820.7A patent/EP3653055A1/en not_active Withdrawn
-
2004
- 2004-03-03 IL IL160720A patent/IL160720A/en active IP Right Grant
- 2004-03-05 NO NO20040965A patent/NO338147B1/no not_active IP Right Cessation
-
2008
- 2008-05-29 US US12/129,549 patent/US20080254064A1/en not_active Abandoned
- 2008-09-19 AU AU2008221592A patent/AU2008221592B2/en not_active Ceased
-
2011
- 2011-07-04 JP JP2011148711A patent/JP5777956B2/ja not_active Expired - Fee Related
-
2012
- 2012-04-18 IL IL219266A patent/IL219266A/en active IP Right Grant
-
2015
- 2015-03-02 JP JP2015040165A patent/JP6114768B2/ja not_active Expired - Fee Related
- 2015-11-16 NO NO20151562A patent/NO20151562A1/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005505270A5 (enExample) | ||
| Urdahl et al. | Initiation and regulation of T-cell responses in tuberculosis | |
| JP2014511704A5 (enExample) | ||
| US9492529B2 (en) | Method for priming of T cells | |
| Yanagibashi et al. | Bacteroides induce higher IgA production than Lactobacillus by increasing activation-induced cytidine deaminase expression in B cells in murine Peyer’s patches | |
| JP2013533745A5 (enExample) | ||
| AR107278A1 (es) | Procedimientos de producción de linfocitos t y linfocitos t producidos por ellos | |
| JP2012518409A5 (enExample) | ||
| Hou et al. | Host response to Sendai virus in mice lacking class II major histocompatibility complex glycoproteins | |
| JP2011500592A5 (enExample) | ||
| JP2011525191A5 (enExample) | ||
| WO2022052984A1 (en) | Universal sars-cov-2 vaccine and preparation method thereof | |
| Larssen et al. | Allogenicity boosts extracellular vesicle–induced antigen-specific immunity and mediates tumor protection and long-term memory in vivo | |
| JP2010538649A5 (enExample) | ||
| Shi et al. | Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro | |
| RU2015101110A (ru) | Вакцинные композиции с катионными липидами и способы применения | |
| MX2013013228A (es) | Particulas similares a virus y proceso para prepararlas. | |
| JP2011522835A5 (enExample) | ||
| CN112048001A (zh) | 一种肿瘤新生抗原多肽及其应用 | |
| JP2010538619A5 (enExample) | ||
| Gedvilaite et al. | Virus-like particles derived from major capsid protein VP1 of different polyomaviruses differ in their ability to induce maturation in human dendritic cells | |
| Ni et al. | Antitumor vaccination by Newcastle Disease Virus Hemagglutinin–Neuraminidase plasmid DNA application: Changes in tumor microenvironment and activation of innate anti-tumor immunity | |
| IL265942B1 (en) | A nucleotide sequence expressing an exosome anchor protein for use as a component | |
| CN119876273B (zh) | 一种嵌合抗原受体nk细胞的制备方法及其应用 | |
| JP2025504109A (ja) | Ｅｂｖ複合抗原、樹状細胞ワクチンおよびその使用 |